Compare DexCom, Inc. (DXCM) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Wheaton Precious Metals Corp — how do they compare? DexCom, Inc. trades at $78.49 (market cap $28.06B), while Wheaton Precious Metals Corp trades at $104.73 (market cap $48.80B). The key difference: Wheaton Precious Metals Corp is the larger of the two by market cap, and Wheaton Precious Metals Corp pays a 0.72% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WPM | |
|---|---|---|
Market Cap | $28.06B | $48.80B |
Sector | Health | Basic Materials |
52-Week High | $89.53 | $165.72 |
52-Week Low | $54.84 | $88.32 |
Enterprise Value | $27.03B | $46.65B |
Dividend Yield | — | 0.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Wheaton Precious Metals (WPM) trades at $108.49, up 0.61% on the day, amid a bearish technical signal but strong fundamental performance. The company reported record operating cash flow of $1.9 billion in 2025, with revenue surging to $2.31 billion and net income reaching $1.47 billion. Recent quarterly earnings have consistently beaten expectations, and analyst consensus remains strongly bullish with an 80% buy rating and a $161.75 price target, suggesting significant upside from current levels.
The outlook for WPM is positive, driven by robust cash flow generation, production growth, and favorable precious metal exposure. Key risks include sensitivity to commodity price volatility and macroeconomic pressures. With a high valuation (P/E 27.43) but strong profitability (ROE 21.54%), the stock presents a growth opportunity tempered by market cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
